Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta M Alonso

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Neuro-Oncology|August 16, 2024
The emerging field of viroimmunotherapy for pediatric brain tumorsMarc Garcia-Moure, Virginia Laspidea, Sumit Gupta, et al.
Frontiers in Oncology|March 30, 2018
DNX-2401, an Oncolytic Virus, for the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Gliomas: A Case ReportSonia Tejada, Ricardo Díez-Valle, Pablo D Domínguez, et al.
Plos One|September 27, 2016
Analysis of SOX2-Regulated Transcriptome in Glioma Stem CellsArlet M Acanda de la Rocha, Hernando López-Bertoni, Elizabeth Guruceaga, et al.
Plos One|January 26, 2016
Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01Beatriz Vera, Naiara Martínez-Vélez, Enric Xipell, et al.
Plos One|June 10, 2016
Correction: Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01Beatriz Vera, Naiara Martínez-Vélez, Enric Xipell, et al.
Journal of the National Cancer Institute|September 13, 2007
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell deathHong Jiang, Candelaria Gomez-Manzano, Hiroshi Aoki, et al.
Oncotarget|February 25, 2016
Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomasNahir Cortes-Santiago, Mohammad B Hossain, Konrad Gabrusiewicz, et al.
Neoplasia (New York, N.Y.)|May 27, 2023
Translational considerations for immunotherapy clinical trials in pediatric neuro-oncologyJessica B Foster, Marta M Alonso, Elias Sayour, et al.
Neuro-Oncology Advances|October 15, 2019
GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memoryYisel Rivera-Molina, Hong Jiang, Juan Fueyo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecanCandelaria Gomez-Manzano, Marta M Alonso, W K Alfred Yung, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Neuro-Oncology|August 16, 2024
The emerging field of viroimmunotherapy for pediatric brain tumorsMarc Garcia-Moure, Virginia Laspidea, Sumit Gupta, et al.
Frontiers in Oncology|March 30, 2018
DNX-2401, an Oncolytic Virus, for the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Gliomas: A Case ReportSonia Tejada, Ricardo Díez-Valle, Pablo D Domínguez, et al.
Plos One|September 27, 2016
Analysis of SOX2-Regulated Transcriptome in Glioma Stem CellsArlet M Acanda de la Rocha, Hernando López-Bertoni, Elizabeth Guruceaga, et al.
Plos One|January 26, 2016
Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01Beatriz Vera, Naiara Martínez-Vélez, Enric Xipell, et al.
Plos One|June 10, 2016
Correction: Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01Beatriz Vera, Naiara Martínez-Vélez, Enric Xipell, et al.
Journal of the National Cancer Institute|September 13, 2007
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell deathHong Jiang, Candelaria Gomez-Manzano, Hiroshi Aoki, et al.
Oncotarget|February 25, 2016
Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomasNahir Cortes-Santiago, Mohammad B Hossain, Konrad Gabrusiewicz, et al.
Neoplasia (New York, N.Y.)|May 27, 2023
Translational considerations for immunotherapy clinical trials in pediatric neuro-oncologyJessica B Foster, Marta M Alonso, Elias Sayour, et al.
Neuro-Oncology Advances|October 15, 2019
GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memoryYisel Rivera-Molina, Hong Jiang, Juan Fueyo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecanCandelaria Gomez-Manzano, Marta M Alonso, W K Alfred Yung, et al.
Pageof 11